Trademark: 79121314
Status Date
Friday, February 26, 2021
Registration Number
4449450
Registration Date
Tuesday, December 17, 2013
Filing Date
Tuesday, October 9, 2012
Published for Opposition
Tuesday, October 1, 2013
Cancellation Date
Friday, February 26, 2021
5 Pharmaceutical preparations and substances, namely, antibiotics, anticonvulsants, antiepileptic preparations and substances for the treatment of cardiological diseases, bone diseases, oncology, gynecology, rhumatology, phlebology and dermatological disorders and diseases; chemical reagents for medical and veterinary use; diagnostic preparations for medical and veterinary use
35 Administrative processing of applications for marketing release authorization and regulatory approval of pharmaceutical and medical products; electronic data collection and data submission services for commercial purposes provided in connection with clinical research, testing, trials and finalization of pharmaceutical products, medical devices and biotechnology
1 Chemical preparations for industrial and scientific use, including for diagnostic use; chemical reagents other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary use; chemical substances, namely, reagents for chemical analysis in laboratories
45 Regulatory compliance consultancy in the field of pharmaceutical products, medical devices and biotechnology products
44 Consultancy in the field of medical treatments and advice in the pharmaceutical field
42 Consulting in the field of pharmaceutical science; research, design and development in the medical and pharmaceutical field; development of medicines for others; conducting clinical and preclinical trials and supervision of clinical and preclinical trials; development of medicines in compliance with regulatory requirements; conducting clinical trials for others in the field of medicine compatibility; pharmacovigilance services for others, namely, monitoring the quality and efficacy of pharmaceutical preparations; consultancy in the field of medical and pharmaceutical research; providing advice in connection with clinical trial research, testing and evaluation of pharmaceutical products, medical devices and biotechnology; evaluating medicines of others to assure compliance with regulatory requirements; providing data analysis of data obtained in connection with clinical trial research and testing of pharmaceutical products, medical devices and biotechnology; scientific research relating to the evaluation of new medicines; development of pharmaceutical preparations, remedies and medicines; technological services, namely, scientific research, analysis and testing in the pharmaceutical and health care sector; scientific research and analysis, namely, conducting early evaluations in the field of new pharmaceutical preparations; scientific research and development in the pharmaceutical field; scientific research and development, namely, conducting clinical trials of medicines of others; product development in the field of medicine
Color is not claimed as a feature of the mark.
The wording "STRAGEN" has no meaning in a foreign language.
Jun 7, 2023
Correction From The Ib Examined, No Action Is Needed
Apr 11, 2023
Correction Transaction Received From Ib
Apr 5, 2023
Final Decision Transaction Processed By Ib
Jan 11, 2023
Generic Madrid Transaction Sent To Ib
Jan 11, 2023
Invalidation Reviewed - No Action Required By Office
Jan 11, 2023
Generic Madrid Transaction Created
Nov 1, 2022
International Registration Renewed
Oct 26, 2021
Total Invalidation Of Reg Ext Protection Created
Feb 26, 2021
Cancelled Section 71
May 8, 2020
Final Decision Transaction Processed By Ib
Mar 15, 2018
New Representative At Ib Received
Jun 13, 2014
Final Decision Transaction Processed By Ib
May 9, 2014
Final Disposition Notice Sent To Ib
May 9, 2014
Final Disposition Processed
Mar 17, 2014
Final Disposition Notice Created, To Be Sent To Ib
Dec 17, 2013
Registered-Principal Register
Oct 1, 2013
Published For Opposition
Sep 30, 2013
Notification Processed By Ib
Sep 11, 2013
Notification Of Possible Opposition Sent To Ib
Sep 11, 2013
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 11, 2013
Notice Of Publication
Aug 27, 2013
Law Office Publication Review Completed
Aug 27, 2013
Approved For Pub - Principal Register
Aug 26, 2013
Teas/Email Correspondence Entered
Aug 26, 2013
Correspondence Received In Law Office
Aug 16, 2013
Assigned To Lie
Aug 14, 2013
Notice Of Revival - Mailed
Aug 14, 2013
Teas Response To Office Action Received
Aug 14, 2013
Petition To Revive-Granted
Aug 14, 2013
Teas Petition To Revive Received
May 10, 2013
Attorney Review Completed
May 10, 2013
Limitation Of Goods/Services From Ib Entered
Apr 20, 2013
Limitation Of Goods Received From Ib
Feb 27, 2013
Refusal Processed By Ib
Feb 5, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Feb 5, 2013
Refusal Processed By Mpu
Feb 5, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Feb 4, 2013
Non-Final Action Written
Feb 4, 2013
Assigned To Examiner
Dec 18, 2012
Application Filing Receipt Mailed
Dec 12, 2012
New Application Office Supplied Data Entered
Dec 7, 2012
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
